Diflorasone Diacetate Ointment
Loading...Diflorasone Diacetate Ointment Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
Each gram of diflorasone diacetate ointment contains 0.5 mg diflorasone diacetate in an ointment base.
Chemically, diflorasone diacetate is 6α,9-difluoro-11β,17,21-trihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17,21-diacetate. The structural formula is represented below:
| molecular formula: C26H32F2O7 molecular weight: 494.54 |
Each gram of diflorasone diacetate ointment contains 0.5 mg diflorasone diacetate in an ointment base of glyceryl monostearate, propylene glycol and white petrolatum.
Sources
Diflorasone Diacetate Ointment Manufacturers
-
Taro Pharmaceuticals U.s.a., Inc.
![Diflorasone Diacetate Ointment [Taro Pharmaceuticals U.s.a., Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Diflorasone Diacetate Ointment | Taro Pharmaceuticals U.s.a., Inc.
Diflorasone diacetate ointment should be applied to the affected area as a thin film from one to three times daily depending on the severity or resistant nature of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Diflorasone Diacetate Ointment | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Diflorasone diacetate ointment should be applied to the affected area as a thin film from one to three times daily depending on the severity or resistant nature of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
![Diflorasone Diacetate Ointment [E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5b92dbac-3f28-4c72-b529-7455e1b7b366&name=961ec6d3-69a9-42c8-b0bf-62be0fd55a18-02.jpg)
Login To Your Free Account